Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386,127,219
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
63,874,892
-
Shares change
-
-6,303,177
-
Total reported value, excl. options
-
$295,826,385
-
Value change
-
-$69,618,988
-
Put/Call ratio
-
16%
-
Number of buys
-
65
-
Number of sells
-
-70
-
Price
-
$4.63
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q3 2019
158 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q3 2019.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63,874,892 shares
of 386,127,219 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (6,493,143 shares), Neuberger Berman Group LLC (5,403,886 shares), Levin Easterly Partners LLC (5,018,204 shares), BlackRock Inc. (4,937,207 shares), VANGUARD GROUP INC (4,403,310 shares), Russell Investments Group, Ltd. (4,009,550 shares), Partner Fund Management, L.P. (3,109,179 shares), RENAISSANCE TECHNOLOGIES LLC (2,745,360 shares), Indaba Capital Management, L.P. (2,721,288 shares), and RTW INVESTMENTS, LP (2,109,500 shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.